Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer
- PMID: 8341988
- DOI: 10.3109/00365529309098333
Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer
Abstract
Helicobacter pylori is the major causal factor in chronic gastritis. Its acquisition leads to a chronic, usually lifelong, inflammation of the gastric mucosa, which may gradually progress to atrophy (with intestinal metaplasia) in a significant proportion of infected individuals. This progression is probably multifactorial, being influenced by genetic or environmental factors in addition to H. pylori infection. The pathogenesis of peptic ulcer and gastric cancer is closely associated with H. pylori gastritis and its subsequent atrophic sequelae (atrophic gastritis). H. pylori-induced gastritis is an important risk factor in the multifactorial aetiology of these diseases. It causes a cascade of reactions that damage the gastric mucosa and epithelium in various ways. The specific mechanisms involved are largely unknown. Some are probably bacterium-related reactions, which are influenced by various virulence factors, and others are consequences of the mucosal inflammation and atrophy. The risk of peptic ulcer and gastric cancer in patients with H. pylori gastritis can be summarized as follows: i) the risk of both peptic ulcer and gastric cancer is low in individuals with a normal stomach; ii) the risk of peptic ulcer is approximately ten times higher and the risk of gastric cancer approximately twice as high in patients with non-atrophic H. pylori-positive gastritis as in those with a normal stomach; iii) these risks are further increased (twofold to threefold) when there is antral atrophy; whereas iv) in the presence of corpus atrophy the risk of gastric cancer remains high, but that of peptic ulcer decreases gradually to zero with increasing severity of corpus atrophy.
Similar articles
-
Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae.J Clin Gastroenterol. 2001 Mar;32(3):196-202. doi: 10.1097/00004836-200103000-00003. J Clin Gastroenterol. 2001. PMID: 11246343
-
Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer.Aliment Pharmacol Ther. 1997 Apr;11 Suppl 1:71-88. doi: 10.1046/j.1365-2036.11.s1.5.x. Aliment Pharmacol Ther. 1997. PMID: 9146793 Review.
-
Helicobacter pylori, chronic gastritis and peptic ulcer.Mater Med Pol. 1992 Jul-Sep;24(3):166-8. Mater Med Pol. 1992. PMID: 1307646 Review.
-
Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.Kathmandu Univ Med J (KUMJ). 2007 Jul-Sep;5(3):295-301. Kathmandu Univ Med J (KUMJ). 2007. PMID: 18604043
-
Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?Am J Gastroenterol. 2000 Jan;95(1):114-21. doi: 10.1111/j.1572-0241.2000.01609.x. Am J Gastroenterol. 2000. PMID: 10638568
Cited by
-
In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.Antimicrob Agents Chemother. 2001 Sep;45(9):2455-9. doi: 10.1128/AAC.45.9.2455-2459.2001. Antimicrob Agents Chemother. 2001. PMID: 11502514 Free PMC article.
-
Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases.Biol Pharm Bull. 2009 May;32(5):774-9. doi: 10.1248/bpb.32.774. Biol Pharm Bull. 2009. PMID: 19420741 Free PMC article. Review.
-
Treatment of Helicobacter pylori infection: current status and future concepts.World J Gastroenterol. 2014 May 14;20(18):5283-93. doi: 10.3748/wjg.v20.i18.5283. World J Gastroenterol. 2014. PMID: 24833858 Free PMC article. Review.
-
Association of triglyceride-glucose index with helicobacter pylori infection and mortality among the US population.Diabetol Metab Syndr. 2024 Aug 1;16(1):187. doi: 10.1186/s13098-024-01422-9. Diabetol Metab Syndr. 2024. PMID: 39090745 Free PMC article.
-
Association of CagA and VacA presence with ulcer and non-ulcer dyspepsia in a Turkish population.World J Gastroenterol. 2003 Jul;9(7):1580-3. doi: 10.3748/wjg.v9.i7.1580. World J Gastroenterol. 2003. PMID: 12854168 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical